Pyblast EW authorized in the EU: what manufacturers and biocide distributors must do

Key data

Distributors, manufacturers and professional users of biocides in Spain and other EU countries have a new marketing window open: the biocide Pyblast EW can now be sold and used in several Member States thanks to the Implementing Decision (EU) 2026/2140, published on 29 September 2026. The original authorization was granted by the Slovenian Chemical Substances Office, and the Commission has validated its extension to the rest of the EU under Article 36 of the Regulation (EU) No 528/2012 on biocides.

The key for companies is not just knowing that the product is authorized, but knowing exactly what conditions must be met to operate legally. Non-compliance with those conditions has direct consequences: administrative sanctions and product withdrawal from the market.

What does this regulation establish?

Implementing Decision 2026/2140 activates the mutual recognition mechanism provided for in Article 36 of Regulation (EU) 528/2012. This mechanism allows a biocide already evaluated and authorized in one Member State to be marketed in other EU countries without the need for a complete additional technical evaluation in each of them.

In this specific case:

• The authorized product is the biocide Pyblast EW.
• The original evaluation was carried out by the Slovenian Chemical Substances Office.
• The European Commission has validated that the Slovenian measure can be extended to other Member States.
• The extension is framed within the procedure of Article 36 of Regulation (EU) No 528/2012.
• The specific conditions for marketing and use are set out in the text of the decision.

This mechanism accelerates access to the European market for already evaluated products, but does not eliminate compliance obligations: each company wishing to market or use Pyblast EW must respect the particular conditions established in the decision, which may include use restrictions, labeling requirements or limitations by user type.

Economic and operational impact

For companies in the sector, this decision has a dual reading:

• Commercial opportunity: Manufacturers and distributors already operating with Pyblast EW in Slovenia can now expand their market to other Member States without incurring the costs and time of a complete additional evaluation. This reduces barriers to entry and accelerates commercialization.
• Operational risk: Companies that market or use Pyblast EW without verifying compliance with the specific conditions of the decision are exposed to administrative sanctions and product withdrawal from the market, with the resulting impact on sales, reputation and business relationships.

The operational impact particularly affects three areas of the company:

• Regulatory/legal area: Review of the decision's conditions and adaptation of internal procedures.
• Commercial area: Update of product sheets, contracts with customers and sales documentation.
• Operations area: Training of professional users and review of use protocols in industrial, agricultural or pest control facilities.

Who does it affect?

The sectors and profiles directly impacted by this decision are:

• Biocide manufacturers that produce or market Pyblast EW in the EU.
• Distributors and wholesalers of biocide products operating in Spain or other Member States included in the extension.
• Pest control companies that use Pyblast EW in their professional treatments.
• Agricultural sector that uses this biocide in crop management or facilities.
• Managers of industrial facilities that apply biocides in their maintenance or sanitation processes.
• Regulatory advisors and compliance officers in companies in the chemical and phytosanitary sector.

Practical example

A Spanish pest control company that until now could not access Pyblast EW because the product was only authorized in Slovenia, can now consider incorporating it into its catalog of professional treatments. Thanks to the mutual recognition activated by Decision 2026/2140, it does not need to wait for Spain to complete its own technical evaluation of the product.

However, before marketing or applying it, this company must:

1. Review the specific conditions set out in the decision (use restrictions, authorized user type, labeling requirements).
2. Ensure that its personnel meet the professional qualification requirements required for the use of biocides in Spain.
3. Update its internal documentation and contracts with customers to reflect the correct use of the product.

If it omits any of these steps and is subject to an inspection, it is exposed to administrative sanctions and product withdrawal from its activity, with the economic and reputational cost that this entails.

What should companies do now?

1. Read the full text of Decision 2026/2140 and extract the specific conditions applicable to the marketing and use of Pyblast EW in your Member State.
2. Verify if your activity falls within the authorized scope: type of permitted use, user profile (professional or not), application sectors.
3. Update product documentation: technical sheets, labels, safety data sheets and any marketing material that references Pyblast EW.
4. Train personnel who will use or distribute the product, ensuring they know the approved conditions of use and the risks associated with non-compliance.
5. Review contracts and commercial agreements with customers and suppliers to incorporate current regulatory conditions.
6. Establish a regulatory monitoring system to detect any possible modifications or additional restrictions that may be published on this product in the future.

The risk of not acting is concrete: companies that market or use Pyblast EW without respecting the conditions of the decision are exposed to administrative sanctions and product withdrawal from the market.

Official source

Consult complete regulation in official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602140